Literature DB >> 19527182

Induced pluripotent stem cells at nanoscale.

Dagmar Zeuschner1, Karina Mildner, Holm Zaehres, Hans R Schöler.   

Abstract

Reprogramming of mouse and human somatic cells into induced pluripotent stem (iPS) cells has been made possible with the expression of the transcription factor quartet Oct4, Sox2, c-Myc, and Klf4. Here, we compared iPS cells derived from mouse embryonic fibroblasts with the 4 factors to embryonic stem cells by electron microscopy. Both cell types are almost indistinguishable at the ultrastructural level, providing further evidence for the similarity of these 2 pluripotent stem cell populations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19527182     DOI: 10.1089/scd.2009.0159

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  17 in total

Review 1.  Roles of small molecules in somatic cell reprogramming.

Authors:  Jian-bin Su; Duan-qing Pei; Bao-ming Qin
Journal:  Acta Pharmacol Sin       Date:  2013-06-03       Impact factor: 6.150

2.  Metabolome and metaboproteome remodeling in nuclear reprogramming.

Authors:  Clifford Dl Folmes; D Kent Arrell; Jelena Zlatkovic-Lindor; Almudena Martinez-Fernandez; Carmen Perez-Terzic; Timothy J Nelson; Andre Terzic
Journal:  Cell Cycle       Date:  2013-07-08       Impact factor: 4.534

Review 3.  Pluripotent stem cell energy metabolism: an update.

Authors:  Tara Teslaa; Michael A Teitell
Journal:  EMBO J       Date:  2014-12-04       Impact factor: 11.598

Review 4.  Metabolic restructuring and cell fate conversion.

Authors:  Alessandro Prigione; María Victoria Ruiz-Pérez; Raul Bukowiecki; James Adjaye
Journal:  Cell Mol Life Sci       Date:  2015-01-14       Impact factor: 9.261

5.  Identification of a clonally expanding haematopoietic compartment in bone marrow.

Authors:  Lin Wang; Rui Benedito; M Gabriele Bixel; Dagmar Zeuschner; Martin Stehling; Lars Sävendahl; Jody J Haigh; Hugo Snippert; Hans Clevers; Georg Breier; Friedemann Kiefer; Ralf H Adams
Journal:  EMBO J       Date:  2012-11-27       Impact factor: 11.598

Review 6.  Revisiting Mitochondrial Function and Metabolism in Pluripotent Stem Cells: Where Do We Stand in Neurological Diseases?

Authors:  Carla Lopes; A Cristina Rego
Journal:  Mol Neurobiol       Date:  2016-02-18       Impact factor: 5.590

Review 7.  Energy metabolism in nuclear reprogramming.

Authors:  Clifford D L Folmes; Timothy J Nelson; Andre Terzic
Journal:  Biomark Med       Date:  2011-12       Impact factor: 2.851

8.  Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming.

Authors:  Clifford D L Folmes; Timothy J Nelson; Almudena Martinez-Fernandez; D Kent Arrell; Jelena Zlatkovic Lindor; Petras P Dzeja; Yasuhiro Ikeda; Carmen Perez-Terzic; Andre Terzic
Journal:  Cell Metab       Date:  2011-08-03       Impact factor: 27.287

9.  Nuclear reprogramming with c-Myc potentiates glycolytic capacity of derived induced pluripotent stem cells.

Authors:  Clifford D L Folmes; Almudena Martinez-Fernandez; Randolph S Faustino; Satsuki Yamada; Carmen Perez-Terzic; Timothy J Nelson; Andre Terzic
Journal:  J Cardiovasc Transl Res       Date:  2012-12-18       Impact factor: 4.132

10.  Gingival fibroblasts as a promising source of induced pluripotent stem cells.

Authors:  Hiroshi Egusa; Keisuke Okita; Hiroki Kayashima; Guannan Yu; Sho Fukuyasu; Makio Saeki; Takuya Matsumoto; Shinya Yamanaka; Hirofumi Yatani
Journal:  PLoS One       Date:  2010-09-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.